David Ferachi, MD
Orthopaedic Surgery · Baton Rouge, LANPI 1851576433
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $10,279 of the $16,264 with a category attached, or 63.2%. Ulrich Medical USA, Inc. accounts for 95.2% of it on its own, with 13 other manufacturers making up the rest.
Across 27 payments — averaging $602.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ulrich Medical USA, Inc.$15K
- Zimvie Inc.$161
- Boston Scientific$156
- Cerapedics Inc.$85
- Surgalign Spine Technologies, Inc.$69
- Providence Medical Technology, Inc.$51
- plus $252 from 8 others
What the payments were for
- Royalty or licence$10,27963%
- Consulting fees$5,00031%
- Food & beverage$8245%
- Other$1611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ulrich Medical USA, Inc. | 6 | $15,490 |
| Zimvie Inc. | 2 | $161 |
| Boston Scientific | 4 | $156 |
| Cerapedics Inc. | 1 | $85 |
| Surgalign Spine Technologies, Inc. | 1 | $69 |
| Providence Medical Technology, Inc. | 1 | $51 |
| Abbott | 2 | $50 |
| Amgen | 3 | $47 |
| Seaspine Orthopedics Corporation | 1 | $39 |
| Stryker | 1 | $37 |
| Sanara Medtech Inc. | 2 | $23 |
| Medtronic | 1 | $23 |
| Integrity Implants Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
How this compares
$16,264 in reported general payments places this provider in the 80th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 414 | $3,266 |
| Meloxicam | 174 | $561 |
| Methylprednisolone | 99 | $538 |
| Cyclobenzaprine Hcl | 122 | $411 |
| Methocarbamol | 74 | $349 |
| Diclofenac Sodium | 24 | $308 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $208 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $176 |
| Tizanidine Hcl | 12 | $58 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Baton Rouge
- Christopher HarrodBaton Rouge$3M
- Jorge IsazaBaton Rouge$1.2M
- Kevin McCarthyBaton Rouge$594K
- Robert EastonBaton Rouge$394K
- Ricardo RodriguezBaton Rouge$262K
- Wame WaggenspackBaton Rouge$82K
- Shaun AccardoBaton Rouge$52K
- Kevin RicheBaton Rouge$33K
- William ShermanBaton Rouge$29K
- Vinod DasaKenner$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.